• Latest Posts
More News! 19 Nov 2018

Anti-Inflammatory Treatments Get €40M Boost in Series B

Oxford Biotech Launches with €26M to Target ‘Immunometabolism’

Septic Shock Drug Shows Promise for Personalized Medicine

More News! 24 Aug 2018

Shire gets US market approval for rare inflammatory disease drug

Swedish Biotech Breaks Barrier to Diagnosis with Rheumatoid Arthritis Test

ADVERTISEMENT

Israeli Crohn’s Disease Drug Rakes in Positive Phase III Results

Series A Round Could Bring French Microbiome Treatment for Bowel Disease Into the Clinic

Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD

German DNA Treatment Reduces Ulcerative Colitis Symptoms

Interview 11 Apr 2018

Forget Humira, a New Generation of Inflammation Treatments is on the Horizon

Stem Cell Therapy for Crohn’s Disease Approved in Europe

ADVERTISEMENT